A sensation built to make you scratch
Itch is one of the most primal sensations, shared widely across animals and important for their well-being [3]. That framing helps explain why it feels so insistent: the sensation is tightly coupled to a behavior, scratching, and the relief that follows. Shakespeare reportedly described itch as the disease of kings because of the pleasurable relief scratching brings [1].
The awkward part is that itch itself cannot be seen on the skin. What an observer notices is only the result of scratching, rubbing, pinching, or pressing [1]. That is one reason itch has stayed scientifically puzzling despite being universally familiar: researchers have to rely on a person's own description of a private sensation, and even the words people use vary between languages and dialects [1].
Dedicated nerve endings carry the message
The body does not treat itch as a mild form of pain. In the outer layer of skin, the epidermis, there are selective nerve endings of the C or Aδ type that act as pruriceptors, meaning nerve endings specialized for detecting itch [2]. These peripheral neurons connect onward to spinal neurons and interneurons, and many areas of the central nervous system take part in processing the signal [2].
A leading model holds that itch is separated from pain by itch-specific neuropeptides, small signaling molecules that relay itch information to the spinal cord. In this model, ordinary neurotransmitters pass, inhibit, and modulate itch signals depending on context, place, and timing, but do not themselves encode itch specifically; gastrin-releasing peptide (GRP) is proposed as a key itch-specific neuropeptide, with spinal neurons carrying its receptor forming part of a convergent circuit that carries itch information to the brain [3]. This is a proposed model rather than a settled map, but it captures the core idea: itch has its own dedicated signaling route.
The immune system is often what sets itch off
Itch usually arises from interactions between the nervous system and the immune system, and it does not occur only because of parasitic, allergic, or immunological disease [2]. Histamine, the substance most people associate with itching, is involved in only a minority of itchy conditions. Many other mediators play a role, including cytokines such as IL-4, IL-13, IL-31, IL-33, and TSLP, along with neurotransmitters and neurotrophins, and ion channels such as TRPV1, TRPA1, and TRPM8 are described as crucial [2].
Which mediator matters can depend on the situation. In one study, levels of the signaling molecule IL-33 were elevated in patients with atopic dermatitis and in those with chronic pruritus of unknown origin, as well as in the corresponding mouse models. When the IL-33 receptor was removed from sensory neurons in mice, itch in an atopic-dermatitis-like disease still occurred, but the development of dry skin itch was blocked [5]. The authors read this as evidence that IL-33 may be a predominant mediator of itch in certain contexts, depending on the tissue environment [5] — a context-dependent role, not a universal one.
Why long-lasting itch can amplify itself
Acute itch is one thing; chronic itch often behaves differently. Chronic itch is frequently linked to neural sensitization, a process in which the nervous system becomes hypersensitive to stimuli, much as it does in chronic pain [4]. In the periphery, inflammation and neuroimmune interactions produce lasting changes in nerve fibers that amplify itch signaling. In the spinal cord, itch-activating pathways become hyperactive, spinal inhibitory circuits malfunction, and inhibitory signals coming down from above are weakened. In the brain, itch-associated areas and networks show structural and functional changes [4].
This helps explain a familiar and frustrating experience: once itch has persisted, it can grow out of proportion to whatever started it. The original trigger and the amplified sensation become separate problems, which is also why treatments are being developed to target these sensitization mechanisms rather than only the initial cause [4].
What itch fundamentally is, then, is fairly settled: an unpleasant sensation with a built-in urge to scratch, carried by specialized nerve endings and shaped by immune signaling. What remains less settled is the fine detail — how the many mediators and pathways combine in each condition, and how to measure a sensation that only the person feeling it can describe [1][2].
Sources used in this answer
Itch – The major symptom of skin disease and yet still enigmatic
Itch, or pruritus, is best defined by the centuries-old description as an untoward sensation inducing the urge to scratch, and it is the major symptom of skin disease, though its mechanisms remain incompletely understood.
Basic mechanisms of itch
Itch is an unpleasant sensation leading to a desire to scratch, detected by selective C or Aδ epidermal nerve endings and usually arising from neuro-immune interactions in which histamine plays only a minority role.
A neuropeptide code for itch
Itch appears to be distinguished from pain by itch-specific neuropeptides relaying signals to the spinal cord, with gastrin-releasing peptide proposed as a key itch-specific neuropeptide acting through GRP-receptor spinal neurons.
Itch: from the skin to the brain – peripheral and central neural sensitization in chronic itch
Chronic itch is frequently linked to neural sensitization, in which peripheral and central itch pathways become hypersensitive through inflammatory, spinal, and brain-level changes.
IL-33 signaling in sensory neurons promotes dry skin itch
IL-33 signaling in sensory neurons was required for dry skin itch in a mouse model but was dispensable for itch in an atopic-dermatitis-like model, suggesting its role depends on the tissue environment.